Ipamorelin

Ipamorelin is a selective, synthetic pentapeptide growth hormone secretagogue that targets the ghrelin receptor (GHSR-1a) to modulate pituitary growth hormone (GH) release in non-human test subjects. As a class II GHSR agonist, it exhibits high specificity for GH secretion with minimal perturbation of cortisol and prolactin release, distinguishing it from other growth hormone-releasing peptides (GHRPs).

Ipamorelin’s efficacy in modulating the somatotropic axis without significant endocrine disruption makes it a valuable tool in preclinical research aimed at studying growth hormone dynamics, metabolic regulation, and tissue repair mechanisms in non-human lab subjects.